University of Alabama at Birmingham: Head and Neck Neoplasms trials

The registry lists 18 Head and Neck Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 4 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 3Phase 2 7Phase 3 1Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer SurvivorsNot yet recruitingNCT07740616Not applicable
• Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap HarvestNot yet recruitingNCT07558096Not applicable
• A Motion Exergaming Approach for Symptom Management: HNCRecruitingNCT04632654Not applicable
• Phase II Panitumumab-IRDye800 in Head & Neck CancerRecruitingNCT04511078Phase 2
• Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck CancerTerminatedNCT03938337Phase 2Results posted
• UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck CancerCompletedNCT00570232Phase 2Results posted
• Dynasplint Therapy for Trismus in Head and Neck CancerCompletedNCT00507208Not applicableResults posted
• Robotic Assisted Surgery in Upper Aerodigestive Tract SurgeryCompletedNCT00473564Not applicableResults posted
• The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer SurgeryCompletedNCT05061316Not applicable
• Mood Disorders in Head and Neck Cancer PatientsWithdrawnNCT04977271Phase 4
• Chemo-embolization for Head and Neck CancerWithdrawnNCT04595981Phase 2
• Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck CancerCompletedNCT03317730Early Phase 1
• Diet Intervention, Head and Neck Cancer, FeasibilityCompletedNCT03013699Not applicable
• Resistance Training and Physical Functioning in Head and Neck Cancer PatientsCompletedNCT01332682Phase 1
• Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal CancerCompletedNCT00827164Phase 2
• Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00318890Phase 1/2
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or LarynxTerminatedNCT00004227Phase 3
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation TherapyStatus unknownNCT00004226Phase 1/2